|
⚲
|
| Keyboard |
| Matthew Scholz | |
|---|---|
| Firm | |
| Address | c/o Oisin Biotechnologies, Inc 800 5th Avenue, Suite 4100 Seattle, WA 98104 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Oisin Biotechnologies Inc | 021-518582 | Executive Officer | 5.4 M of 17.9 M |
||
| Immusoft Corp | 021-515744 | Director | 4.6 M of 10.0 M |
||
| Oisin Biotechnologies Inc | 021-409178 | Executive Officer | 0.5 M of 5.0 M |
||
| Oncosenx Inc | 021-409051 | Executive Officer | 0.7 M of 5.0 M |
||
| Immusoft Corp | 021-376212 | Director | 10.3 M of 11.0 M |
||
| Oisin Biotechnologies Inc | 021-369506 | Executive Officer | 9.5 M of 9.5 M |
||
| Oisin Biotechnologies Inc | 021-361313 | Executive Officer | 3.0 M of 3.0 M |
||
| Oncosenx Inc | 021-343617 | Executive Officer | 4.1 M of 5.5 M |
||
| Immusoft Corp | 021-303485 | Director | 20.2 M of 23.4 M |
||
| Immusoft Corp | 021-273572 | Executive Officer | 2.7 M of 4.6 M |
||
| Immusoft Corp | 021-246031 | Executive Officer | 0.4 M of 1.0 M |
||
| Immusoft Corp | 021-223329 | Executive Officer | 2.4 M of 3.3 M |
||